Journal
Global Heart
Publication Date
5-3-2024
Volume
19
Issue
1
First Page
44
Document Type
Open Access Publication
DOI
10.5334/gh.1323
Rights and Permissions
Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, Houehanou C, Norov B, Karki KB, Azangou-Khyavy M, Marcus ME, Aryal KK, Brant LCC, Theilmann M, Cífková R, Lunet N, Gurung MS, Mwangi JK, Martins J, Haghshenas R, Sturua L, Vollmer S, Bärnighausen T, Atun R, Sussman JB, Singh K, Moghaddam SS, Guwatudde D, Geldsetzer P, Manne-Goehler J, Huffman MD, Davies JI, Flood D. Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data. Glob Heart. 2024 May 3;19(1):44. doi: 10.5334/gh.1323. © 2024 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 license (unless stated otherwise) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Yoo, Sang Gune K; Huffman, Mark D; and et al., "Global prevalence of aspirin use for primary prevention of cardiovascular disease: A cross-sectional study of nationally representative, individual-level data." Global Heart. 19, 1. 44 (2024).
https://digitalcommons.wustl.edu/oa_4/3809
Department
ICTS (Institute of Clinical and Translational Sciences)
